Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer
Journal
Lung Cancer
Journal Volume
144
Pages
10-19
Date Issued
2020
Author(s)
Peters S.
Shaw A.T.
Besse B.
Felip E.
Solomon B.J.
Soo R.A.
Bearz A.
Gadgeel S.M.
Kao S.
Seto T.
Masters E.T.
Abbattista A.
Clancy J.S.
Thurm H.
Reisman A.
Peltz G.
Ross Camidge D.
SDGs
Publisher
Elsevier Ireland Ltd
Type
journal article